{"id":540,"date":"2023-05-01T14:53:42","date_gmt":"2023-05-01T13:53:42","guid":{"rendered":"http:\/\/molecularhealth.com\/eu\/?page_id=540"},"modified":"2025-03-30T11:50:01","modified_gmt":"2025-03-30T10:50:01","slug":"charite-institute-of-pathology","status":"publish","type":"page","link":"https:\/\/molecularhealth.com\/eu\/charite-institute-of-pathology\/","title":{"rendered":"Charit\u00e9 Institute of Pathology"},"content":{"rendered":"
\r\n
\r\n
\r\n
\r\n \r\n
\r\n

Charit\u00e9 Institute of Pathology
A long-standing collaboration
enables pan-cancer therapy \r\n <\/h1>\r\n <\/div>\r\n \r\n
<\/i> Other case studies<\/span><\/a><\/div> <\/span>\r\n <\/div>\r\n\r\n \r\n
\r\n

The Institute of Pathology at the Charit\u00e9 Berlin is a key player in the care of cancer patients of the country\u2019s capital and surrounding area. Their broad spectrum of analytical methods covers histological, cytological, and molecular diagnostics to deliver the reliable and timely identification of therapeutic options. A long-standing collaboration between the Charit\u00e9 Institute of Pathology and Molecular Health enables interdisciplinary, pan-cancer therapy decisions in the molecular tumor board.<\/p><\/span>\r\n <\/div>\r\n \r\n <\/div>\r\n<\/div>\r\n\r\n

\r\n

The Institute of Pathology at the Charit\u00e9 Berlin is a key player in the care of cancer patients of the country\u2019s capital and surrounding area. Their broad spectrum of analytical methods covers histological, cytological, and molecular diagnostics to deliver the reliable and timely identification of therapeutic options. A long-standing collaboration between the Charit\u00e9 Institute of Pathology and Molecular Health enables interdisciplinary, pan-cancer therapy decisions in the molecular tumor board.<\/p><\/span>\r\n <\/div>\r\n<\/div>\n\n\n

\n
\n
<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

\u201cWe\u2019ve been using MH Guide for several years in our laboratory and are very satisfied with its flexible application across the different tumor types, being processed and evaluated in our laboratory.\u201d<\/p>\n\n\n\n

Prof. Dr. Michael Hummel<\/strong>
Former Head of Molecular Pathology at the Institute of Pathology, Charit\u00e9 Berlin<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Challenge<\/strong><\/h3>\n\n\n\n

To meet the rising demand in molecular analyses of a wide range of tumor types, the Institute of Pathology at the Charit\u00e9 Berlin looked to implement an effective and comprehensive solution for results interpretation of next-generation sequencing (NGS) data.<\/p>\n<\/div>\n<\/div>\n\n\n\n

Solution<\/strong><\/h3>\n\n\n\n

Molecular Health supports clinical routines in the Charit\u00e9 Institute of Pathology with the evaluation of NGS data from molecular analyses of various cancer types. The MH Guide software enables the rapid and transparent interpretation of molecular analyses, delivering patient-specific results in customized reports. MH Guide is used especially in the evaluation of large gene panels to perform the parallel analysis of multiple disease-relevant genes and the automated identification of diagnostic mutations.<\/p>\n\n\n\n

Patient benefit<\/strong><\/h3>\n\n\n\n

The long-standing collaboration between the Institute of Pathology at the Charit\u00e9 Berlin and Molecular Health grants patients access to personalized cancer treatment and to relevant clinical trials based on individual molecular tumor profiles. The partnership fosters the rapid, evidence-based interpretation of molecular diagnostic outcomes for all cancer types and, thus, promotes effective discussions among the interdisciplinary members of the molecular tumor board.<\/p>\n\n\n

<\/div>\n\n\n

More case studies<\/h2>\n\n\n
\r\n\r\n
\r\n \r\n
\r\n \r\n
\r\n \"\"\r\n
\r\n

GENOPATH GbR<\/h2>\r\n

A group of pathology labs make top-quality, cutting-edge molecular diagnostics a priority<\/h3>\r\n View<\/a> <\/div>\r\n <\/div>\r\n
\r\n \"\"\r\n
\r\n

OncoNet Rhein-Main e. V.<\/h2>\r\n

A healthcare network provides effective and targeted cancer care <\/h3>\r\n View<\/a> <\/div>\r\n <\/div>\r\n
\r\n \"\"\r\n
\r\n

Gen Era Diagnostics<\/h2>\r\n

A leading provider of molecular diagnostics products and services in Turkey offers MH Guide<\/h3>\r\n View<\/a> <\/div>\r\n <\/div>\r\n
\r\n \"\"\r\n
\r\n

GENOPATH GbR<\/h2>\r\n

A group of pathology labs make top-quality, cutting-edge molecular diagnostics a priority<\/h3>\r\n View<\/a> <\/div>\r\n <\/div>\r\n
\r\n \"\"\r\n
\r\n

OncoNet Rhein-Main e. V.<\/h2>\r\n

A healthcare network provides effective and targeted cancer care <\/h3>\r\n View<\/a> <\/div>\r\n <\/div>\r\n
\r\n \"\"\r\n
\r\n

Gen Era Diagnostics<\/h2>\r\n

A leading provider of molecular diagnostics products and services in Turkey offers MH Guide<\/h3>\r\n View<\/a> <\/div>\r\n <\/div>\r\n <\/div>\r\n \r\n
<\/div>\r\n\r\n \r\n
<\/div>\r\n
<\/div>\r\n\r\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"

\u201cWe\u2019ve been using MH Guide for several years in our laboratory and are very satisfied with its flexible application across the different tumor types, being processed and evaluated in our laboratory.\u201d Prof. Dr. Michael HummelFormer Head of Molecular Pathology at the Institute of Pathology, Charit\u00e9 Berlin Challenge To meet the rising demand in molecular analyses […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":""},"class_list":["post-540","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/comments?post=540"}],"version-history":[{"count":13,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/540\/revisions"}],"predecessor-version":[{"id":3970,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/540\/revisions\/3970"}],"wp:attachment":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/media?parent=540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}